Rating History for Akcea Therapeutics, Inc. (AKCA) by BMO Capital

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/1/2020 Do Kim Downgrade Market Perform
(Outperform)
18.15
(26.00)
11.38
(18.17)
59.67% Details